Memantine may Not Benefit Patients With Mild Alzheimer's Disease

by Kathy Jones on  April 12, 2011 at 6:36 PM Clinical Trials News
RSS Email Print This Page Comment bookmark
Font : A-A+

In patients with mild Alzheimer's disease (AD) and mild cognitive impairment, the Alzheimer's drug memantine may not be useful, an analysis of studies has revealed.
 Memantine may Not Benefit Patients With Mild Alzheimer's Disease
Memantine may Not Benefit Patients With Mild Alzheimer's Disease

Researchers at the University of Southern California Keck School of Medicine, Los Angeles analyzed randomized, placebo-controlled, parallel-group clinical trials of memantine that involved patients with mild to moderate AD. A systematic search yielded three trials that involved 431 patients with mild AD and 697 patients with moderate AD.

"There were no significant differences between memantine and placebo on any outcome for patients with mild AD, either within any trial or when data were combined," the authors led by Lon S. Schneider reported.

Memantine is a drug that has been approved for moderate to severe AD. However it is frequently prescribed off-label for mild AD and mild cognitive impairment as well. But as this analysis shows, it may not have any beneficial effects in mild disease.

The study details have been posted online today and are due to appear in the August issue of Archives of Neurology, one of the JAMA/Archives journals.


Source: Medindia

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Alzheimers Disease Creutzfeldt-Jakob Disease Diet and Alzheimer´s Disease Genetics of Alzheimer´s disease 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

News Category

News Archive

Loading...